Cellares, which is known for producing the technology used in cell therapy manufacturing, has raised $255 million in a Series C as it aims to build out its own manufacturing business.
Fabian Gerlinghaus The company’s thinking is that contract manufacturers are not currently able…
Click here to view original post
